Literature DB >> 16621366

Gels as vaginal drug delivery systems.

J das Neves1, M F Bahia.   

Abstract

The vagina has been used as a mucosal drug delivery route for a long time. Its single characteristics can be either limitative or advantageous when drug delivery is considered. Gels are semi-solid, three-dimensional, polymeric matrices comprising small amounts of solid, dispersed in relatively large amounts of liquid, yet possessing more solid-like character. These systems have been used and are receiving a great deal of interest as vaginal drug delivery systems. Gels are versatile and have been used as delivery systems for microbicides, contraceptives, labour inducers, and other substances. Although somewhat neglected in clinical studies, pharmaceutical characterization of vaginal gels is an important step in order to optimize safety, efficacy and acceptability. Indeed, the simple formulation of a gel can lead to different performances of systems containing the same amount of active substances. Therefore, this paper discusses and summarizes current use and research of vaginal drug delivery systems based in gels.

Mesh:

Substances:

Year:  2006        PMID: 16621366     DOI: 10.1016/j.ijpharm.2006.03.012

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  36 in total

1.  Submicron Matrices Embedded in a Polymeric Caplet for Extended Intravaginal Delivery of Zidovudine.

Authors:  Felix Mashingaidze; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Vinesh Maharaj; Eckhart Buchmann; Viness Pillay
Journal:  AAPS J       Date:  2017-08-04       Impact factor: 4.009

2.  Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.

Authors:  José das Neves; Johan Michiels; Kevin K Ariën; Guido Vanham; Mansoor Amiji; Maria Fernanda Bahia; Bruno Sarmento
Journal:  Pharm Res       Date:  2011-11-10       Impact factor: 4.200

3.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

Review 4.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

Review 5.  Vaginal drug distribution modeling.

Authors:  David F Katz; Andrew Yuan; Yajing Gao
Journal:  Adv Drug Deliv Rev       Date:  2015-04-28       Impact factor: 15.470

6.  Designing hydrogels for controlled drug delivery.

Authors:  Jianyu Li; David J Mooney
Journal:  Nat Rev Mater       Date:  2016-10-18       Impact factor: 66.308

Review 7.  Biomaterials and Contraception: Promises and Pitfalls.

Authors:  Isabella Claure; Deborah Anderson; Catherine M Klapperich; Wendy Kuohung; Joyce Y Wong
Journal:  Ann Biomed Eng       Date:  2019-11-07       Impact factor: 3.934

8.  Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model.

Authors:  Valence M K Ndesendo; Viness Pillay; Yahya E Choonara; Lisa C du Toit; Eckhart Buchmann; Leith C R Meyer; Riaz A Khan; Uwe Rosin
Journal:  AAPS PharmSciTech       Date:  2010-05-06       Impact factor: 3.246

9.  Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation.

Authors:  Raghavendra S Navath; Anupa R Menjoge; Hui Dai; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Mol Pharm       Date:  2011-06-20       Impact factor: 4.939

10.  Characterization of the rheological, mucoadhesive, and drug release properties of highly structured gel platforms for intravaginal drug delivery.

Authors:  Gavin P Andrews; Louise Donnelly; David S Jones; Rhonda M Curran; Ryan J Morrow; A David Woolfson; R Karl Malcolm
Journal:  Biomacromolecules       Date:  2009-09-14       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.